Literature DB >> 2297706

Characterization of a cathepsin L-like enzyme secreted from human pancreatic cancer cell line HPC-YP.

N Yamaguchi1, S M Chung, O Shiroeda, K Koyama, J Imanishi.   

Abstract

Spent culture medium from the human pancreatic carcinoma cell line HPC-YP, which can propagate in a protein-free, chemically defined medium without any other supplements, was analyzed for the presence of the cysteine protease, cathepsin L. The secreted form of cathepsin L was distinguished from the lysosomal form by its increased stability at alkaline pH, by its strong thermostability, and by its larger molecular size. HPC-YP cathepsin L was still stable at pH 7.4 and at 56 degrees C after 60-min preincubation. The molecular weight of this enzyme was estimated to be 68,000, compared with a molecular weight of 29,000 for normal liver cathepsin L. By Western blot analysis, HPC-YP enzyme was found to be composed of two components, one with a molecular weight of 37,000 and the other of 31,000. This result suggests that HPC-YP enzyme in the spent medium may be a complex of the proenzyme (in the case of liver proenzyme; Mr 39,000) and the mature enzyme (in the case of liver mature enzyme; Mr 29,000). Interestingly, an intrinsic inhibitor was also separated from the spent medium by gel filtration. The molecular weight of this inhibitor was estimated to be approximately 13,000. The cathepsin L of HPC-YP proved more resistant toward leupeptin than did liver cathepsin L. On the other hand, the former was more sensitive than the latter toward the diazomethane inhibitors, Z-Phe-Phe-CHN2 and Z-Phe-Ala-CHN2. These results indicate that cathepsin L secreted from cancer cell lines may play a role in the destruction of basal lamina, invasion of tissue, and formation of metastasis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297706

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

Review 1.  Proteases and proteolysis in the lysosome.

Authors:  P Bohley; P O Seglen
Journal:  Experientia       Date:  1992-02-15

2.  Structural requirements for cathepsin B and cathepsin H inhibition by kininogens.

Authors:  B Bano; S P Kunapuli; H N Bradford; R W Colman
Journal:  J Protein Chem       Date:  1996-08

3.  Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo.

Authors:  K Menzel; M Hausmann; F Obermeier; K Schreiter; N Dunger; F Bataille; W Falk; J Scholmerich; H Herfarth; G Rogler
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

4.  Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.

Authors:  M Niedergethmann; R Hildenbrand; G Wolf; C S Verbeke; A Richter; S Post
Journal:  Int J Pancreatol       Date:  2000-08

5.  Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase.

Authors:  J M Delaissé; P Ledent; G Vaes
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

Review 6.  The baculoviruses occlusion-derived virus: virion structure and function.

Authors:  Jeffery Slack; Basil M Arif
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.